Text

POLA PENGGUNAAN OBAT SEMAGLUTIDE PADA PASIEN DIABETES MELITUS TIPE 2 DI RS SILOAM SRIWIJAYA PALEMBANG PERIODE JANUARI 2024-JANUARI 2025

---

Background: Semaglutide is a GLP-1 receptor agonist used as a therapy to improve glycemic control in patients with Type 2 Diabetes Mellitus. Although its use continues to increase globally, data regarding the utilization pattern of this drug in Indonesia, remains scarce. Objective: To determine the pattern of semaglutide use among T2DM patients at Siloam Sriwijaya Hospital Palembang from January 1, 2024, to January 1, 2025, based on indication, dosing, drug interactions, and contraindications. Methods: This retrospective descriptive study analyzed secondary data from electronic medical records employing a total sampling technique. From a total population of 2,612 T2DM patients, 66 subjects using semaglutide met the inclusion criteria. In this study, data analysis was conducted using SPSS. Results: The prevalence of T2DM was 59.5% among the diabetic population, with a predominance of male (56.1%) and adult (84.8%) patients. Clinically, 54.5% of patients had controlled random blood glucose (

---

Availability

Detail Information

Series Title

-

Call Number

T1876412025

Publisher

Palembang : Prodi Pendidikan Dokter, Fakultas Kedokteran Universitas Sriwijaya., 2025

Collation

xix, 90 hlm.; ilus.; tab, 29 cm

Language

Indonesia

ISBN/ISSN

-

Classification

616.460 7

Content Type

Text

Media Type

unmediated

Carrier Type

other (computer)

Edition

-

Subject(s)

Diabetes Mellitus
Prodi Pendidikan Dokter

Specific Detail Info

-

Statement of Responsibility

SEW

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment